These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 33822486)

  • 61. The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage.
    Hänle-Kreidler S; Richter KT; Hoffmann I
    J Biol Chem; 2022 Dec; 298(12):102703. PubMed ID: 36395886
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of CDC4/FBXW7 in gastric carcinoma.
    Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
    Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
    Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
    J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer.
    Qiu F; Jin Y; Pu J; Huang Y; Hou J; Zhao X; Lu Y
    Exp Cell Res; 2021 Oct; 407(2):112807. PubMed ID: 34487730
    [TBL] [Abstract][Full Text] [Related]  

  • 65. FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.
    Saffie R; Zhou N; Rolland D; Önder Ö; Basrur V; Campbell S; Wellen KE; Elenitoba-Johnson KSJ; Capell BC; Busino L
    Cancer Res; 2020 Jun; 80(12):2498-2511. PubMed ID: 32350066
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma.
    El-Mezayen H; Yamamura K; Yusa T; Nakao Y; Uemura N; Kitamura F; Itoyama R; Yamao T; Higashi T; Hayashi H; Imai K; Chikamoto A; Yamashita YI; Baba H
    Ann Surg Oncol; 2021 Nov; 28(12):7973-7982. PubMed ID: 33886022
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice.
    Onoyama I; Nakayama KI
    Cell Cycle; 2008 Nov; 7(21):3307-13. PubMed ID: 18948752
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genetic reevaluation of the role of F-box proteins in cyclin D1 degradation.
    Kanie T; Onoyama I; Matsumoto A; Yamada M; Nakatsumi H; Tateishi Y; Yamamura S; Tsunematsu R; Matsumoto M; Nakayama KI
    Mol Cell Biol; 2012 Feb; 32(3):590-605. PubMed ID: 22124152
    [TBL] [Abstract][Full Text] [Related]  

  • 69. FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1.
    Mori A; Masuda K; Ohtsuka H; Shijo M; Ariake K; Fukase K; Sakata N; Mizuma M; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Fujishima F; Unno M
    Cancer Sci; 2018 Dec; 109(12):3883-3895. PubMed ID: 30302867
    [TBL] [Abstract][Full Text] [Related]  

  • 70. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
    Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
    Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c-Myc and p53 substrates in patients with dysplastic nevi or melanoma.
    Mozuraitiene J; Gudleviciene Z; Vincerzevskiene I; Laurinaviciene A; Pamedys J
    Oncol Lett; 2021 Jan; 21(1):37. PubMed ID: 33262829
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fbxw7-dependent degradation of Notch is required for control of "stemness" and neuronal-glial differentiation in neural stem cells.
    Matsumoto A; Onoyama I; Sunabori T; Kageyama R; Okano H; Nakayama KI
    J Biol Chem; 2011 Apr; 286(15):13754-64. PubMed ID: 21349854
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The promotional effect of microRNA-103a-3p in cervical cancer cells by regulating the ubiquitin ligase FBXW7 function.
    Ren L; Yang J; Meng X; Zhang J; Zhang Y
    Hum Cell; 2022 Mar; 35(2):472-485. PubMed ID: 35094292
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    Liu QX; Zhu Y; Yi HM; Shen YG; Wang L; Cheng S; Xu PP; Xu HM; Zhou LT; Huang YH; Huang CX; Fu D; Ji MM; Wang CF; Zhao WL
    Int J Biol Sci; 2024; 20(10):3972-3985. PubMed ID: 39113693
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Skp1-Cullin-F-box (SCF)-type ubiquitin ligase FBXW7 negatively regulates spermatogonial stem cell self-renewal.
    Kanatsu-Shinohara M; Onoyama I; Nakayama KI; Shinohara T
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8826-31. PubMed ID: 24879440
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
    Guo Z; Zhou Y; Evers BM; Wang Q
    Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
    [TBL] [Abstract][Full Text] [Related]  

  • 79. FBXW7 in breast cancer: mechanism of action and therapeutic potential.
    Chen S; Leng P; Guo J; Zhou H
    J Exp Clin Cancer Res; 2023 Sep; 42(1):226. PubMed ID: 37658431
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.
    Xie CM; Tan M; Lin XT; Wu D; Jiang Y; Tan Y; Li H; Ma Y; Xiong X; Sun Y
    Cell Rep; 2019 Mar; 26(11):3037-3050.e4. PubMed ID: 30865892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.